Dr. Xiaoyan Wang serves as IMO’s Senior Vice President of Life Sciences Solutions. Prior to IMO, she was the Chief Scientific Officer at Melax Tech. She also previously served as the VP of Healthcare Analytics and Informatics and VP of Biopharma Solutions at GeneDx, where she led the development of clinical evidence generation platforms and clinical research in oncology, immunology, cardiovascular, respiratory, and rare diseases. Dr. Wang is a former faculty member and principal investigator at the University of Connecticut, UConn Health Center, and Mount Sinai Health Systems. She holds a Master of Arts in Genetics from the University of Kansas, and a Doctor of Philosophy in Biomedical Informatics and NLP from Columbia University School of Medicine.